Inflammatory bowel disease patients prioritize mucosal healing, symptom control, and pain when choosing therapies: results of a prospective cross-sectional willingness-to-pay study

BACKGROUND: Given the large armamentarium of therapies for inflammatory bowel disease (IBD), physicians cannot fully describe all treatments to patients and, therefore, make assumptions regarding treatment attributes communicated to patients. This study aimed to assess out-of-pocket willingness-to-p...

Descripción completa

Detalles Bibliográficos
Autores principales: Gregor, James C, Williamson, Martin, Dajnowiec, Dorota, Sattin, Bernie, Sabot, Erik, Salh, Baljinder
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903497/
https://www.ncbi.nlm.nih.gov/pubmed/29692603
http://dx.doi.org/10.2147/PPA.S152872

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5903497/
https://www.ncbi.nlm.nih.gov/pubmed/29692603
http://dx.doi.org/10.2147/PPA.S152872

Ejemplares similares